Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.
Frequently asked questions
What sector does Orphazyme A/S (OZYMF) operate in?
Orphazyme A/S belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Orphazyme A/S (OZYMF) current stock price?
As of the latest data, Orphazyme A/S stock price is $90.00, with a previous close of $90.00.
What is Orphazyme A/S (OZYMF) current market capitalization?
Orphazyme A/S market cap is approximately 4.84 million.
What is Orphazyme A/S (OZYMF) Earnings Per Share (EPS)?
The trailing EPS is -$2,471.19.
What is Orphazyme A/S (OZYMF) EBITDA?
Orphazyme A/S EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -923.70 thousand.
Does Orphazyme A/S (OZYMF) pay dividends?
No. Orphazyme A/S does not pay a dividend.
What is Orphazyme A/S (OZYMF) beta (volatility) score?
Orphazyme A/S has a beta of 0.287, indicating lower volatility than the overall market.
